Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03310658
Other study ID # ZHP01-1.0
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 17, 2017
Est. completion date May 30, 2018

Study information

Verified date October 2017
Source ZSX Medical LLC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

ZSX Medical completed enrollment in its First in Human Ease of Use study in May of 2017, in Monterrey Mexico. The purpose of this study is to demonstrate the ease of use of Zip-Stitch™, to generate first in human data, and to refine surgical technique of the device.

Ten subjects were enrolled and received total laparoscopic hysterectomies, including vaginal cuff closure with the Zip-Stitch™ system during their otherwise standard care. Procedures took place over the course of one week. Subjects had in person follow-up appointments at 1 and 6 weeks. Subjects are continuing follow-up through a one-year extension period which will end in May 2018.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date May 30, 2018
Est. primary completion date June 30, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Provision of signed and dated Informed Consent Form

- Stated willingness to comply with all study procedures, including participation in follow-up visits and telephonic follow-up

- Female, age 18 years or older

- Indicated for Total Laparoscopic Hysterectomy

Exclusion Criteria:

- HIV

- Hepatitis C

- Diabetics

- Use of systemic corticosteroids

- History of pelvic irradiation

- Active infection

- History of bleeding problems/hemophilia

- Cancer

- Cases in which vaginal cuff closure is intended to be performed robotically

- Pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Zip-Stitch Soft Tissue Closure System
The novel Zip-Stitch System employed a laparoscopic applicator, a series of bio-absorbable clips, and an application procedure to close the vaginal cuff during otherwise standard of care total laparoscopic hysterectomy.

Locations

Country Name City State
Mexico Hospital Universitario: Universidad Autónoma de Nuevo León de Monterrey Monterrey Nuevo León

Sponsors (1)

Lead Sponsor Collaborator
ZSX Medical LLC

Country where clinical trial is conducted

Mexico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Device Ease of Use Ease of Use of the Zip-Stitch Soft Tissue Closure System during Total Laparoscopic Hysterectomy. Assessed following surgery by standardized surgeon interview. Immediately following procedure
Secondary Vaginal Cuff Closure Assessment of quality of vaginal cuff closure following uterine excision. Performed by surgeon as operative standard of care. During procedure.
Secondary Vaginal Cuff Closure Time Procedural time from uterine excision to successful vaginal cuff closure. During Procedure.
Secondary Total Surgical Time Total procedural time. During Procedure.
Secondary Device Use Learning Curve assessed with a Surgeon Survey Investigation of change in effectiveness of device implementation as assessed by change in efficiency of device use. Assessed immediately following study completion during surgeon survey.
Secondary Sexual Discomfort Measurement of subject discomfort during sexual activity following completion of surgical procedure. Assessed with 1-10 scale (1 = No Pain, 10 = Most Pain). Assessed at 1 and 6 week follow-up visits.
See also
  Status Clinical Trial Phase
Completed NCT04082039 - Two-channel Intravenous Patient-controlled Analgesia (IV-PCA) After Total Laparoscopic Hysterectomy (TLH) N/A
Recruiting NCT05720884 - Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy N/A
Completed NCT02293369 - Comparison of Two Methods of Vaginal Cuff Closure at Laparoscopic Hysterectomy N/A
Recruiting NCT06111404 - Urinary Bladder Dissection During Total Laparoscopic Hysterectomy in Cases With Previous Cesarean Section N/A
Completed NCT05003297 - Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) as an Inflammatory Markers to Predict Length of Hospital Stay After Total Laparoscopic Hysterectomy (TLH) for Benign Indications
Recruiting NCT01289314 - Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy N/A
Recruiting NCT05028543 - TLH With Prior Uterine Artery Clipping at Its Origin Versus Conventional TLH N/A